What is in this article?:
- Yum lowers 4Q sales guidance for China a second time
- Waiting out a media storm
Sales and traffic for KFC China decreased significantly in December following consumer reaction to a government review of China's poultry supply.
Louisville, Ky.-based Yum! Brands Inc. has warned investors for the second time in two months that same-store sales will fall in the fourth quarter in its crucial China division, revising the expected decline down further on fallout from KFC China’s supply chain controversy.
In a statement released Monday Yum updated its expectations for the China division’s fourth-quarter same-store sales down to a 6-percent decrease from a previously forecasted 4-percent decline. The company said it lowered its guidance “due to adverse publicity associated with a government review of China poultry supply and the corresponding significant impact on KFC China sales during the last two weeks of December.”
Yum, which also is the parent to Pizza Hut and Taco Bell, derives about 40 percent of its operating profit from the fast-growing China region.
A long December
Yum previously released a same-store sales guidance for the fourth quarter on Nov. 29 after Chinese state television broke a story in mid-November that two suppliers that had worked with KFC China allegedly used antibiotics and hormones to accelerate the growth of their chickens. That model said fourth-quarter same-store sales would decline about 4 percent in China.
According to securities analysts, Yum China stated publicly last year that the suppliers in question supplied a very small percentage of their total chicken purchases and that they had stopped procurement from those sources in August 2012. But the hit to KFC’s quality perceptions in China appeared to worsen in December, analysts noted, as Chinese regulators became more involved.
“In December,” analyst Andy Barish of Jefferies Equity Research wrote in a research note, “the Shanghai Food & Drug Administration then tested KFC samples, where it found that while KFC’s chicken was in compliance with safety standards, some samples did reveal high levels of an antibiotic, necessitating additional checks. In response, Yum publicly announced that it was cooperating fully with the authorities and noted a moderate impact to sales.”
Sales and traffic for KFC China decreased significantly as December wore on. In one research note, Jeff Farmer of Wells Fargo Securities estimated that Yum’s new guidance of a 6-percent decline in fourth-quarter same-store sales in China implies a 12-percent drop for the whole month of December. He and other observers speculated that trends were even harsher in the last two weeks of 2012, with comparable sales falling between 15 percent and 20 percent.
Farmer wrote that investors should not confuse the antibiotic-related headwinds with the challenges Yum already was facing in China from that country’s slowed growth, noting that Yum’s Nov. 29 guidance update came before the Shanghai FDA released the results of its findings. He added that Yum’s same-store sales growth in China has tracked closely with macroeconomic trends that are “lukewarm at best,” including an accelerating year-over-year change in Yuan deposits, a moderation in the China Wage Index, and decelerating year-over-year growth in disposable income.